Contract W911QY21C0031
Merck Sharp & Dohme Llc · Department Of Defense · September 10, 2021
Merck Sharp & Dohme Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 10, 2021 for $2.20 billion (current value) of work in pharmaceutical preparation manufacturing. Performance is in Kenilworth, NJ. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $3.70 billion.
Contract details
- PIID
- W911QY21C0031
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Kenilworth, NJ
- First action
- September 10, 2021
Description
COVID-19: ADMIN MODIFICATION TO CORRECT LANGUAGE IN SECTION H.4(B).
Modification timeline
-
September 10, 2021Mod P00002 · Other Administrative Action$2.20B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911QY21C0031?
Contract W911QY21C0031 is a federal contract awarded to Merck Sharp & Dohme Llc by Department Of Defense on September 10, 2021 for $2.20 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W911QY21C0031?
Merck Sharp & Dohme Llc won contract W911QY21C0031 from Department Of Defense.
How much is contract W911QY21C0031 worth?
Contract W911QY21C0031 has obligated $0 to date but carries a potential ceiling of $3.70 billion if fully funded and all options are exercised.